Capital Research Global Investors’s Mesoblast MESO Stock Holding History

Capital Research Global Investors’s Portfolio MESO Stock Details MESO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	–	Sell	-226,400	Closed	-$2.49M	–	456
2018 Q2	$2.49M	Hold	226,400	–	–	﹤0.01%	427
2018 Q1	$2.62M	Hold	226,400	–	–	﹤0.01%	430
2017 Q4	$2.64M	Hold	226,400	–	–	﹤0.01%	417
2017 Q3	$2.48M	Hold	226,400	–	–	﹤0.01%	420
2017 Q2	$3.6M	Hold	226,400	–	–	﹤0.01%	425
2017 Q1	$4.07M	Hold	226,400	–	–	﹤0.01%	417
2016 Q4	$2.43M	Hold	226,400	–	–	﹤0.01%	422
2016 Q3	$1.95M	Hold	226,400	–	–	﹤0.01%	410
2016 Q2	$1.8M	Hold	226,400	–	–	﹤0.01%	416
2016 Q1	$4.36M	Hold	226,400	–	–	﹤0.01%	423
2015 Q4	$2.88M	Buy	+226,400	New	+$2.77M	﹤0.01%	430

Other funds holding MESO

Prudential plc London, England, United Kingdom $17.1B AUM 15.7% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Penbrook Management New York $157M AUM 46.57% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

PCM

Princeton Capital Management Red Bank, New Jersey $367M AUM 45.24% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Stifel Financial St. Louis, Missouri $109B AUM 21.36% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

OWD

Osborn Williams & Donohoe Cincinnati, Ohio $762M AUM 2.74% 1-Year Est. Return

Capital Research Global Investors's MESO Position: Q3 2018 in Review

Capital Research Global Investors sold out of Mesoblast (MESO) in Q3 2018, closing a stake of 226,400 shares — an estimated $2.49M sold.

Capital Research Global Investors first reported a position in MESO in Q4 2015 and held it in 11 quarters. The position peaked at $4.36M in Q1 2016. 23 funds tracked by Wall St. Rank hold MESO as of Q3 2018.

Capital Research Global Investors reported no remaining Mesoblast position as of Q3 2018 after selling out during the quarter.
Capital Research Global Investors sold 226,400 Mesoblast shares in Q3 2018, an estimated $2.49M.
Capital Research Global Investors first reported a position in Mesoblast in Q4 2015 and held it in 11 quarters.
Capital Research Global Investors's Mesoblast position peaked at $4.36M in Q1 2016.
23 funds tracked by Wall St. Rank held Mesoblast as of Q3 2018.

Based on Capital Research Global Investors's 13F filing for Q3 2018, filed 14 Nov 2018.